arrow
A

Adrian J. Thrasher

ucl great ormond street institute of child health
H指数:108
被引数:4.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and biochemical correction of a patient with neurodegenerative Mucopolysaccharidosis IIIA using hematopoietic stem cell gene therapy

使用造血干细胞基因疗法对神经退行性黏多糖贮积症IIIA患者进行临床和生化纠正

2026-09-250
PRE
Unveiling the cut-and-repair cycle of designer nucleases in human stem and T cells via CLEAR-time dPCR

通过清除时间dPCR揭示人类干细胞和T细胞中设计核酸酶的切割和修复周期

2025-11-030
OAAI
Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency

腺苷脱氨酶缺乏症的基因治疗长期安全性与有效性

2025-10-160
PRE
Preclinical evaluation of lentiviral gene therapy for adenosine deaminase 2 deficiency (DADA2): engraftment efficiency and biodistribution in humanised NBSGW mice

腺苷脱氨酶2缺乏症(DADA2)的慢病毒基因治疗临床前评估:人源化NBSGW小鼠中的植入效率和生物分布

2025-06-240
OAAI
Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency
2024-11-190
OAAI
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial

Betibeglogene autotemcel基因治疗输血依赖性,严重基因型 β-地中海贫血 (HGB-212) 患者: 一项非随机,多中心,单臂,开放标签,单剂量,3期试验

LANCET
IF88.5
2024-11-010
PRE
Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy

慢病毒基因治疗脑型肾上腺脑白质营养不良

2024-10-104
PRE
Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach
2024-08-011
OA
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia
2024-07-010
OAAI
AAV capsid bioengineering in primary human retina models
2023-12-117
OAAI
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials
2023-03-016
OAAI
Access to gene therapy for rare diseases when commercialization is not fit for purpose

当商业化不适合目的时,获得罕见疾病的基因治疗

2023-02-1328
PRE
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy
2023-02-019
OAAI
Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria
2022-09-099
OAAI